Prophylactic Aspirin and Public. - sprookjes - yvandenbroek - TriplyDB

Prophylactic Aspirin and Public.

Prophylactic Aspirin and Public.

http://www.wikidata.org/entity/Q54682804

about

Prophylactic Aspirin and Public.

http://www.wikidata.org/entity/Q54682804

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

Prophylactic Aspirin and Public.

@en

Prophylactic Aspirin and Public.

@nl

type

label

Prophylactic Aspirin and Public.

@en

Prophylactic Aspirin and Public.

@nl

prefLabel

Prophylactic Aspirin and Public.

@en

Prophylactic Aspirin and Public.

@nl

P1433

Q54682804-207772F5-3501-469F-B564-DE240B5FE284

P1476

Q54682804-742828DA-CAE7-4083-8891-E3145212AED9

P2093

Q54682804-4F23ADF6-A7FE-4E11-B137-2266D3FD11F3

P2860

Q54682804-03191B69-658E-494C-9F38-4354242AF716

Q54682804-0662C105-7321-4127-B4A7-A3B7BC63E003

Q54682804-151DDEE7-ABF9-4137-92C0-DEAC03EB41A8

Q54682804-1D2F5CE4-3A42-454A-B90C-AFFFC2D4F8B1

Q54682804-279470AB-5E76-4A19-854E-E4A65E645D7F

Q54682804-2A6A9542-D1A5-409B-BC43-BE494279CCAE

Q54682804-32916857-0838-435C-A2BE-4049D0664E93

Q54682804-3F8097CC-202F-44B1-A22C-5B3E2A8F8678

Q54682804-401D47E0-2A18-4B2A-AD5E-EF2C5EE88663

Q54682804-42AAECBB-A9CC-4E37-A869-BE4B393056A5

P304

Q54682804-9B62621E-5BE8-4F32-A827-B8781C486A32

P31

Q54682804-0BCA99CB-2038-46A0-8209-83F03094E3AF

P356

Q54682804-D25350A1-0EB8-4383-A8ED-ED446442DFF7

P433

Q54682804-ECCA4214-83FE-4E59-AF49-E956FD444F2D

P478

Q54682804-E4AD0CF7-6E79-435F-8561-4CC978BF2F40

P577

Q54682804-4D2236F4-8D4E-4F5E-8FDB-6E3546451FC6

P698

Q54682804-338BA3DA-A846-4A5D-AA90-B15FA4577EF3

P932

Q54682804-78BF5B54-F9CA-4FC6-89B9-BA45E92B4E04

P356

PUBLICHEALTH.2013.1.1

P1433

AIMS public health

P1476

Prophylactic Aspirin and Public.

@en

P2093

Gareth Morgan

http://www.w3.org/2001/XMLSchema#string

P2860

Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials

A prospective study of aspirin use and the risk for colorectal adenoma

Aspirin for everyone older than 50? For

Risk of hemorrhagic stroke with aspirin use: an update

Aspirin use among U.S. adults: Behavioral Risk Factor Surveillance System

A randomized trial of aspirin to prevent colorectal adenomas

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials.

Aspirin for the prevention of cardiovascular disease: U.S. Preventive Services Task Force recommendation statement.

My health: whose responsibility? A jury decides.

P304

1-8

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3934/PUBLICHEALTH.2013.1.1

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

1

http://www.w3.org/2001/XMLSchema#string

P577

2013-10-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29666823

http://www.w3.org/2001/XMLSchema#string

P932

5903373

http://www.w3.org/2001/XMLSchema#string